Main Article Content
On the other hand, only a few risk factors are considered by the risk scores established (FRAMINGHAM, PROCAM, ESC and HEART score, for instance). Thus, a relevant proportion of patients affected with myocardial infarction or other cardiovascular events do not belong to a high risk group according to these scores.
Thus, alternative tools for universal risk calculation are desirable to improve the significance and sensitivity of such estimations.
Based on “traditional“ risk factors considered by the scores mentioned, mathematical analyses were carried out to describe coincidences of various risk factors with regard to the resulting total risk. Their quantitative synergism and relativity can be mathematically described by a specific hyperbolic tangent function derived from the PROCAM score.
By other formulas PROCAM risk calculated in this way can be transformed into corresponding FRAMINGHAM and ESC risk which are targeted at other critical end points.
We consider that the special interaction of risk factors described in our mathematical models can be regarded as a general law of nature so that our formulas could be used for universal risk estimations in all risk constellations imaginable, even when multiple risk factors are coincident.
The Medical Research Archives grants authors the right to publish and reproduce the unrevised contribution in whole or in part at any time and in any form for any scholarly non-commercial purpose with the condition that all publications of the contribution include a full citation to the journal as published by the Medical Research Archives.
 Arad Y, Spadaro LA, Goodman K (2000) Prediction of coronary events with electron beam cumputed tomography. J. Am. Coll. Cardiol., 36, 1253 – 1260
 Assmann, G.: PROCAM health check. Risk factor-based calculator for evaluating individual risk for myocardial infarction, PrevaMed GmbH, interactive DC-ROM for physicians, 2007
 Assmann G, Cullen,P, von Eckardstein A, Funke H, Schulte H (1999) The importance of triglycerides as a significant risk factor. Eur. Heart, J., 1, J 7 – J 11
 Assmann G, Cullen P, Schulte H (2002) Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the Prospective Cardiovascular Münster (PROCAM) Study. Circulation, 105, 310-315
 Borch-Johnsen K, Feldt-Rasmussen B, Strandgaard S, Schroll M, Jensen JS (1999) Urinary albumin excretion. An independent predictor of ischemic heart disease. Arterioscler Thromb Vasc Biol 19:1992-1997
 Chrubasik-Hausmann, S., Chrubasik, C. (†), Piper, J., Schulte-Mönting, J, Erne, P.
Impact of Risk Factors on Cardiovascular Risk: a Perspective on Risk Estimation in a Swiss Population. Swiss Med Wkly, 2015 (in press)
 Clarke R, Lewintron S, Donald A (2001) Underestimation of the importance of homocsteine as a risk factor for cardiovascular disease in epidemiological studies. J. Cardiovasc Risk, 8, 363 – 369
 Clerarfield MB (2005) C-reaktives Protein: A new risk assessment tool for cardiovascular disease. JAOA, 105/9: 409 – 416
 Conroy RM, Pyörälä K, Fitzgerald AP et al, on behalf of the SCORE project group (2003) Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Result of a riks estimation study in Europe. Eur Heart J. 24: 987 – 1003
 Craig WY, Neveux LM, Palomaki GE (1998) Lipoprotein(a) as a risk factor for ischemic heart disease: metaanalysis of prospective studies. Clin. Chem., 44: 2301 – 2306.
 European Society of Cardiology (2005) Heartscore: the interactive tool for predicting and managing the risk of heart attack and stroke in Europe.
 Fruchart JC, Nierman MC, Stroes ESG, Kastelein JJP, Duriez P (2004) New Risk Factors for Atherosclerosis and Patient Risk Assessment. Circulation, 109(23 suppl. 1), III 15 – III 19
 Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B, Halle JP, Young J, Rashkow A, Joyce C, Nawaz S, Yusuf S (2001) Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. Jama 286:421-426
 Grundy SM (2001) Coronary calcium as a risk factor: role in global risk assessment. J. Am. Coll. Cardiol., 27, 1512 – 1515
 Harvard school of puplic health (2005) Health weight. www.hsph.harvard.edu
 Hillege HL, Fidler V, Diercks GF, van Gilst WH, de Zeeuw D, van Veldhuisen DJ, Gans RO, Janssen WM, Grobbee DE, de Jong PE (2002) Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 106:1777-1782
 Hillege HL, Janssen WM, Bak AA, Diercks GF, Grobbee DE, Crijns HJ, Van Gilst WH, De Zeeuw D, De Jong PE (2001) Microalbuminuria is common, also in a nondiabetic, nonhypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular morbidity. J Intern Med 249:519-526
 Hopkins PN, Wu LL, Hunt SC, Brinton EA (2005) Plasma triglycerides and type III hyperlipidemia are independently associated with premature familial coronary artery disease. J. Am. Coll. Cardiol., 45(7), 1003 – 1012
 International Task Force for Prevention of Coronary Heart Disease (2005) Procam Risik Calculator. www.chd-taskforce.com/index.html
 Klausen K, Borch-Johnsen K, Feldt-Rasmussen B, Jensen G, Clausen P, Scharling H, Appleyard M, Jensen JS (2004) Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes. Circulation 110:32-35
 Luc G, Bard JM, Arveiler D (2002) Lipoprotein (a) as a predictor of coronary heart desease: the PRIME Study. Atherosclerosis, 163, 377 – 384
 National Heart Lung, and Blood Institute, National Institute of Health (2002) Framingham Heart Study. www.nhlbi.nih.gov/about/framingham/index.html
 Nurk E, Tell GS, Vollset SE (2002) Plasma total homocysteine and hospitalizations for cardiovascular disease: the Hordalend Homocysteine Study. Arch. Intern. Med., 162, 1374 – 1381
 Raggi P, Callister TQ, Cooil B, He ZX, Lippolis N J, Russo D, Zelinger A, Mahmarian J (2000) Identification of patients at increased risk of first unheralded acute myocardial infarction by electron-beam computed tomography. Circulation 101, 850 – 855
 Remuzzi G, Weening JJ (2005) Albuminuria as early test for vascular disease. Lancet 365:556-557
 Rexrode KM (2001) Abdominal and total adiposity and risk of coronary heart disease in Men. Int. J. Obes. 25, 1047 – 1056
 Ridker PM, Hennekens CH, Buring JE (2000) C-reactive protein and other markeers of inflammation in the prediction of cardiovascular disease in women. N. Engl. J. Med., 342, 836 – 843
 Rifai N, Ridker PM (2001) Proposed cardovascular risk assessment algorithen using high-sensitivity C-reaktive Protein and Lipid Scorering. Clinical Chemistry 47: 28 – 30
 Saikku P, Leinonen M, Tenkanen L, Ekman MR, Linnanmärki E, Manninen V, Mänttäri M, Frick MM, Huttunen JK (1992) Chronic Chlamydia pneumonoae infection as a risk factor for coronary heart disease in the Helsinki Heart Study Ann Int Med 116; 273-278
 Scarabin PY, Arveiler D, Amouyel P (2003) Plasma fibrinogen explains much of the difference in risk of coronary heart disease between France an Northern Ireland: the PRIME study. Atherosclerosis, 1666, 103 – 109
 Schulte H, Cullen P, Assmann G (1999) Obesity, mortality and cardiovascular disease in the Münster Heart Study (PROCAM). Atherosclerosis, 144, 199 – 209
 Stuveling E.M. HHL, Bakker S.J.L.,Gansevoort R.T.,Gans R.O.B.,de Zeeuw D.,de Jong P. (2003) Urinary albumin excretion and C-reactive protein independently add to the mortality risk. J.Am.Soc.Nephrol. 14:679a
 Swiss Atherosclerosis Association, Arbeitsgruppe Lipide und Atherosklerose (AGLA):
 UK Prospective Diabetes Study (UKPDS) Group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet; 332, 837 – 853
 U.S. Department of health and human services, puplic health service, national institute of health, national cancer institute (2001) Risk associated with smoking. Monography 13 http://www.krebsgesellschaft.de/downlowd/RisksAssociatedwithSmoking.pdf
 Wachtell K, Ibsen H, Olsen MH, Borch-Johnsen K, Lindholm LH, Mogensen CE, Dahlof B, Devereux RB, Beevers G, de Faire U, Fyhrquist F, Julius S, Kjeldsen SE, Kristianson K, Lederballe-Pedersen O, Nieminen MS, Okin PM, Omvik P, Oparil S, Wedel H, Snapinn SM, Aurup P (2003) Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study. Ann Intern Med 139:901-906
 Wang TJ, Larson MG, Levy D (2002) C-reactive protein is associated with subclinical epicardial coronary caldivication in men and women: the Framingham heart Study. Circulation, 106, 1189 – 1191
 Welborn TA, Dhaliwal SS, Bennett SA (2003) Waist-hip ratio is the dominant riskfactor predicting kardiovascular risk in Austria. M. J. A. 179, 580 – 585
 Yusuf S (2004) Effect of protencially modificable risk factors associated with myocardial infarction in 52 countries (the INTERHAERT study): chase control study. Lancet 364, 937 – 952
 Yusuf, S (2005) Obesity and the risk of myocardial infarction in 27000 parcipitens from 52 countries: access control-study. Lancet, 366, 1640 – 1649